ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,837,000 | +0.6% | 39,928 | -3.0% | 0.01% | 0.0% |
| Q3 2018 | $1,826,000 | +12.1% | 41,157 | -1.0% | 0.01% | +25.0% |
| Q2 2018 | $1,629,000 | +564.9% | 41,561 | +1126.0% | 0.00% | +300.0% |
| Q1 2018 | $245,000 | -44.6% | 3,390 | -90.4% | 0.00% | 0.0% |
| Q4 2016 | $442,000 | -9.6% | 35,280 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $489,000 | +40.1% | 35,280 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $349,000 | -41.5% | 35,280 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $597,000 | -23.9% | 35,280 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $785,000 | -5.6% | 35,280 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $832,000 | -64.3% | 35,280 | +23.9% | 0.00% | -62.5% |
| Q2 2015 | $2,329,000 | -11.7% | 28,480 | 0.0% | 0.01% | -11.1% |
| Q1 2015 | $2,637,000 | – | 28,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |